Hebrok Lab

Our lab is studying the mechanisms that underlie mammalian pancreas organogenesis and pancreatic diseases, including diabetes and pancreatic cancer 🧫🔬

[Hebrok Lab @HebrokLab]

At the TUM Center for Organoid Systems (COS) we are looking for a Scientific Operations Manager and an Assistant to the CEO/Board of Directors:https://t.co/JZpNWa8Qe9
https://t.co/iEKcOFZB7q

[Hebrok Lab @HebrokLab]

Congratulations to our senior postdoc and all-around beta cell expert @MaachiHasna for being accepted into the prestigious Helmholtz Munich High Potentials Program (HPP)!

https://t.co/E9JlrcZ2x4
https://t.co/hWjc7MSX7N

[Heiko Lickert @LickertHeiko]

Thrilled to share one of our biggest discoveries: “Inceptor binds to and directs insulin towards lysosomal degradation in beta cells”.
https://t.co/GKx6eslJz0
A tremendous collaborative effort led by @JohannaSiehler, @BilekovaSara and other members of the @LickertHeiko lab.

[Hebrok Lab @HebrokLab]

Publication alert 🚨

Happy to share our work on engineered suppressor cells for localized immunosuppression, e.g. for T1D, out in Science: https://t.co/4D5pI2va0O

Fantastic collaboration with the teams of Wendell Lim and Audrey Parent at UCSF @CDI_UCSF @AParent_lab @AtUcsf

[Hebrok Lab @HebrokLab]

Exciting to hear about the great science of our CPA colleagues at the Summer Party. Congrats to our postdocs Kai Duan and Jia Mei for giving excellent speed talk and poster presentations.

#Science #StemCells #NextGen #Organoids #diabetes #Cancer

[Hebrok Lab @HebrokLab]

Thankful for this exciting opportunity to speak with members of the German Parliament about our research on stem cell based therapies for diabetes.

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

#HelmholtzMunich im #Bundestag: KI & Hightech

Bei der 3. #ExpertHour informierten @fabian_theis @CompHealthMuc & @HebrokLab über die Potenziale von #KI & neuen Technologien, um die Medizin in den Bereichen #Prävention, #Diagnose & #Therapie zu verbessern: https://t.co/Vt7ljKt5AT

[Hebrok Lab @HebrokLab]

Job alert 📢!
We are looking for an enthusiastic postdoc with experience in beta cell biology and/or human stem cell differentiation to join our team. More information here: https://t.co/NlQG6jvvwy

[PanCAN @PanCAN]

For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic #pancreaticcancer, called NALIRIFOX.

After a clinical trial showed a positive survival benefit, the combination chemotherapy called NALIRIFOX is now approved for patients who have not received any previous treatment. For a disease with limited treatment options, this is exciting news. 💜

We've answered some of the most common questions related to this new treatment option at https://t.co/qEiI2JUbiE.

If you have additional questions, you can contact PanCAN Patient Services at 📱 877-2- PANCAN or 📧 [email protected]. Our Case Managers can help you understand your options and connect you with resources to learn more.

[Hebrok Lab @HebrokLab]

Publication alert 🚨:
Our paper about Sox9 regulating alternative splicing in beta cells is out in Nature Communications!
https://t.co/So9kZ0yrH6
Thanks to Sapna and all co-authors for this tremendous work! #splicing #betacells #diabetes #stemcells #Perseverance

[Hebrok Lab @HebrokLab]

I would like to thank the “Bavarian Ministry of Science“ for awarding me the “Bavarian Distinguished Professorship” and the TUM and Helmholtz Munich for their support. It is a great honor for me and my lab to receive this special award.

[TU München @TU_Muenchen]

Congrats to Matthias Hebrok for receiving a Bavarian Distinguished Professorship! He will continue his outstanding work in #stemcell and #organoid research at our university: https://t.co/VH8RbBwDqb

#pancreaticcancer #diabetes #HightechAgendaBayern
@HebrokLab @MIBE_TUM
📷U.Benz

[Hebrok Lab @HebrokLab]

I would like to thank the Heinz Nixdorf Stiftung for their generous and ground-breaking support of an endowed TUM professorship for AI-supported organoid development at the Center for Organoid Systems (COS).

[TU München @TU_Muenchen]

Our #organoid research will be supported by the Heinz Nixdorf Foundation with 3.8 mio. euros. 👏 The findings could be clinically applied, in particular for individualized #cancertherapies: https://t.co/2zbz0h6OIC

#AI #organoidmodels #stemcells
@MIBE_TUM

📷U.Meyer

[Hebrok Lab @HebrokLab]

We are hiring!
One admin and one technician position are available in our lab!

Please find more detailed information:
#adminposition
https://t.co/RnbXw4jCxQ

#technicianposition
https://t.co/q51tL4fFTJ

#hiring #TUM #technischeassistenz #secretary

[Hebrok Lab @HebrokLab]

@fabian_theis @HelmholtzMunich @TU_Muenchen @MIBE_TUM @diabinfodienst @helmholtz_de @helmholtz_diabc Thanks, Fabian. Looking forward to talking soon!

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

Pancreatic organoids👨‍🔬
👉This is what Matthias Hebrok, director of our new Institute for #Diabetes & #Organoid Technology focuses on.

💡His goal: Finding new paths for novel therapies for #diabetes & #pancreaticCancer.
👉Read about his spirit & ideas:
🔗https://t.co/DqS1VrUrhA

[Maike Sander & Lab @msanderlab]

Diabetes Germany reunion at FC Bayern game in Munich. ⁦@LickertHeiko⁩, Matthias Hebrok. ⁦@MatthiasTschop⁩ and Stephan Herzig with season tickets.

[Hebrok Lab @HebrokLab]

🎉We are pleased to announce that Hebrok Lab has started the next chapter of its scientific journey @TU_Muenchen & @helmholtz_diabc . Stay tuned for exciting news about mammalian pancreas organogenesis and pancreatic diseases!

[Helmholtz Diabetes Center (HDC) @helmholtz_diabc]

📢We have a new member in the club: The 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗳𝗼𝗿 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗮𝗻𝗱 𝗢𝗿𝗴𝗮𝗻𝗼𝗶𝗱 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 (𝗜𝗗𝗢𝗧), led by Matthias Hebrok, was founded in September 2022!

We are very much looking forward to working together! 🙌

#WelcomeToTheFamily